Tag Archives: Immunovant

January 13, 2021   No comments

H.C. Wainwright Believes Immunovant (NASDAQ: IMVT) Won’t Stop Here

In a report released today, Douglas Tsao from H.C. Wainwright maintained a Buy rating on Immunovant (IMVT – Research Report), with a price target of $54.00. The company’s shares closed last Tuesday at $46.95, close to its 52-week high of

Read More
August 5, 2020   No comments

Immunovant (IMVT) Gets a Buy Rating from LifeSci Capital

LifeSci Capital analyst Sam Slutsky maintained a Buy rating on Immunovant (IMVT – Research Report) today and set a price target of $32.00. The company’s shares closed last Wednesday at $25.03. According to TipRanks.com, Slutsky is a 1-star analyst with

Read More
July 4, 2020   No comments

Analysts Are Bullish on These Financial Stocks: Immunovant (IMVT), Goldman Sachs Group (GS)

There’s a lot to be optimistic about in the Financial sector as 2 analysts just weighed in on Immunovant (IMVT – Research Report) and Goldman Sachs Group (GS – Research Report) with bullish sentiments. Immunovant (IMVT) In a report issued

Read More
March 4, 2020   No comments

Immunovant (IMVT) Gets a Buy Rating from Nomura

In a report issued on March 2, Christopher Marai from Nomura maintained a Buy rating on Immunovant (IMVT – Research Report), with a price target of $27.00. The company’s shares closed last Monday at $16.36. According to TipRanks.com, Marai is

Read More